XML 30 R17.htm IDEA: XBRL DOCUMENT

Divestiture	12 Months Ended
Divestiture	Sep. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]
Divestiture	Divestitures Advanced Bioprocessing In October 2018, the Company completed the sale of its Life Sciences segment's Advanced Bioprocessing business. The Company recognized a pre-tax gain on the sale of approximately $336 million which was recorded as a component of Other operating expense, net in fiscal year 2019. Vyaire Medical In April 2018, the Company completed the sale of its non-controlling interest in Vyaire Medical. The Company received gross cash proceeds of approximately $435 million and recognized a pre-tax gain on the sale of approximately $303 million, which was recognized in Other income, net.